Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Explore the HIP Breast Cancer Screening Trial
Access to Data

The Health Insurance Plan of Greater New York (HIP) Breast Cancer Screening Trial was a randomized screening study designed to test if breast cancer mortality rates could be reduced through the use of periodic screening. Periodic screening was composed of an initial examination followed by 3 subsequent annual exams. Screening consisted of a clinical breast examination and mammography. The study concluded that periodic screening resulted in a reduced breast cancer mortality rate. The effect appeared to be concentrated in participants over the age of 50.

This website is organized into several sections as follows.